Zanubrutinib for Relapsed/Refractory Mantle Cell Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Zanubrutinib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Blood Adv 2021 Jun 22;5(12)2577-2585, CS Tam, S Opat, D Simpson, G Cull, J Munoz, TJ Phillips, WS Kim, S Rule, SK Atwal, R Wei, W Novotny, J Huang, M Wang, J TrotmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.